iCAC Device vs Mindbowser AI Cardiovascular Risk Prediction
AI Verdict
Choose iCAC Device if…
Choose the iCAC Device if your radiology department aims to opportunistically identify and quantify coronary artery calcium (CAC) from existing, routine non-contrast, non-gated chest CT scans. This tool is ideal for enhancing early cardiovascular disease detection by providing precise CAC burden estimates without requiring dedicated cardiac CT protocols or additional patient radiation exposure, seamlessly integrating with PACS/DICOM workflows.
View iCAC Device →Choose Mindbowser AI Cardiovascular Risk Prediction if…
Choose Mindbowser AI Cardiovascular Risk Prediction if your healthcare system or clinic requires a comprehensive, EHR-integrated solution for proactive cardiovascular risk assessment and clinical decision support. This tool is best suited for providers leveraging existing patient data within major EHRs (Epic, Cerner, Athenahealth) to identify at-risk individuals, inform treatment plans, and support population health management initiatives with robust compliance and interoperability.
View Mindbowser AI Cardiovascular Risk Prediction →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | iCAC Device | Mindbowser AI Cardiovascular Risk Prediction |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). | Cloud-based |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Unknown |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
iCAC DeviceTool A, the iCAC Device, integrates directly with existing radiology workflows via PACS or DICOM routers and provides clear visual and quantitative outputs in Agatston units, streamlining the process for radiologists. While Tool B offers broader EHR integration, Tool A's focused integration into the imaging workflow for a specific task likely offers a more immediately usable experience for its target specialists.
Clinical Value
iCAC DeviceTool A, iCAC Device, is an FDA-cleared AI algorithm for detecting and quantifying coronary artery calcium, providing a validated and objective measure for early cardiovascular disease detection. Tool B, while offering AI-powered risk prediction, does not explicitly mention FDA clearance for its predictive models, which is a critical indicator of clinical validation and safety.
Pricing & Value
TieBoth Tool A and Tool B require contacting the vendor for pricing information. Without transparent pricing details or specific return on investment (ROI) metrics for either product, it is impossible to conduct a meaningful comparison of their pricing or overall value proposition.
Enterprise Readiness
Mindbowser AI Cardiovascular Risk PredictionTool B explicitly states HIPAA and SOC 2 compliance, confirms the availability of a Business Associate Agreement (BAA), and details specific EHR integrations (Epic, Cerner, Athenahealth, FHIR) with HL7 & FHIR interoperability. Tool A requires contacting the vendor for these crucial compliance and integration details, making Tool B appear more readily prepared for enterprise deployment.
Innovation
iCAC DeviceTool A, the iCAC Device, is FDA-cleared for the opportunistic identification and quantification of coronary artery calcium from routine, non-contrast, non-gated chest CT scans. This innovative approach leverages existing imaging data for early disease detection without requiring dedicated cardiac scans, representing a significant advancement in population-level screening.
Support & Docs
TieNeither the provided structured facts nor the web search results offer sufficient specific information regarding dedicated customer support channels, comprehensive user manuals, or transparent service level agreements for either tool. While both companies indicate some level of resources or internal documentation, a direct comparison of their support and documentation offerings is not possible.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | iCAC Device | Mindbowser AI Cardiovascular Risk Prediction |
|---|---|---|
| Primary Function | Detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. | AI Cardiovascular Risk Prediction tool, designed for providers and hospitals to assess cardiovascular risks. |
| Supported Specialties | Cardiology, Radiology | Cardiology, Family Medicine, Internal Medicine |
| EHR Integration | Integrates with EHRs via the Carebricks platform | Epic, Cerner, Athenahealth, FHIR (HL7 & FHIR interoperability) |
| Additional Compliance/Certifications | Not specified | SOC 2 compliance |
| Specific AI Analysis Output | Estimates presence and quantity of coronary artery calcium (CAC), provides exact and four-category quantitative estimates of CAC burden in Agatston units, outputs visual representation of estimated CAC segmentation. | AI Cardiovascular Risk Prediction, AI-powered automation, Clinical Decision Support System, Data & Analytics. |
Videos
Demos, reviews, and walkthroughs featuring iCAC Device and Mindbowser AI Cardiovascular Risk Prediction.